Please Wait
| Date | 9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | 3/31/2021 | 12/31/2020 |
|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $107,734,000.00 | $67,440,000.00 | $110,403,000.00 | $50,191,000.00 | -- | -- | -- |
| Accounts Receivable Net Current | $137,000.00 | -- | -- | -- | -- | -- | -- |
| Inventory | $563,000.00 | -- | -- | -- | -- | -- | -- |
| Prepaid Expenses and Other Current Assets | $8,336,000.00 | $9,458,000.00 | $10,283,000.00 | $5,392,000.00 | -- | -- | -- |
| Total Current Assets | $172,199,000.00 | $216,139,000.00 | $265,488,000.00 | $104,951,000.00 | -- | -- | -- |
| Property Plant and Equipement | $2,118,000.00 | $1,857,000.00 | $1,290,000.00 | $474,000.00 | -- | -- | -- |
| Intangible Assets Net | -- | -- | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- | -- | -- |
| Other Assets | $456,000.00 | $456,000.00 | $456,000.00 | -- | -- | -- | -- |
| Total Assets | $181,443,000.00 | $225,240,000.00 | $274,438,000.00 | $105,614,000.00 | -- | -- | -- |
| Accounts Payable | $7,052,000.00 | $8,117,000.00 | $10,045,000.00 | $4,372,000.00 | -- | -- | -- |
| Accrued Liabilities | -- | -- | -- | -- | -- | -- | -- |
| Total Current Liabilities | $37,415,000.00 | $32,451,000.00 | $33,492,000.00 | $17,431,000.00 | -- | -- | -- |
| Long Term Debt | -- | -- | -- | -- | -- | -- | -- |
| Additional Paid-in Capital | $456,263,000.00 | $450,739,000.00 | $444,784,000.00 | $4,667,000.00 | -- | -- | -- |
| Accumulated Other Comprehensive Loss | $-725,000.00 | $-196,000.00 | $-151,000.00 | $9,000.00 | -- | -- | -- |
| Accumulated Deficit | $-311,500,000.00 | $-257,760,000.00 | $-203,700,000.00 | $-155,845,000.00 | -- | -- | -- |
| Total Stockholders' Equity | $144,028,000.00 | $192,789,000.00 | $240,946,000.00 | $-151,168,000.00 | $-124,070,000.00 | $-80,631,000.00 | $-66,725,000.00 |
| Controlling Interest in Subsidiaries | -- | -- | -- | -- | -- | -- | -- |
| Total Liabilities and Equity | $181,443,000.00 | $225,240,000.00 | $274,438,000.00 | $105,614,000.00 | -- | -- | -- |
| Date | 9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | 3/31/2021 | 12/31/2020 |
|---|---|---|---|---|---|---|---|
| Total Revenues | $345,000.00 | -- | -- | -- | $285,000.00 | -- | -- |
| Cost of Revenues | -- | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- | -- |
| Research and Development | $70,637,000.00 | $24,259,000.00 | $21,464,000.00 | -- | $12,853,000.00 | $6,864,000.00 | -- |
| Selling, General, and Administrative | $86,284,000.00 | -- | -- | -- | $24,012,000.00 | -- | -- |
| Total Operating Expenses | -- | $54,253,000.00 | $47,814,000.00 | -- | -- | $12,868,000.00 | -- |
| Loss from Operations | $-156,748,000.00 | $-102,067,000.00 | $-47,814,000.00 | -- | $-22,918,000.00 | $-12,868,000.00 | -- |
| Loss Before Income Taxes | $-53,881,000.00 | $-101,595,000.00 | $-47,702,000.00 | -- | $-23,142,000.00 | $-14,523,000.00 | -- |
| Earnings Per Share Basic | $-2.77 | $-1.85 | -- | -- | $-3.42 | -- | -- |
| Weighted Average Shares Basic | 58,533,226 | 58,275,903 | -- | -- | 6,477,140 | -- | -- |
| Earnings Per Share Diluted | $-0.92 | $-1.85 | -- | -- | $-9.20 | -- | -- |
| Weighted Average Shares Diluted | 58,533,226 | 58,275,903 | -- | -- | 6,477,140 | -- | -- |
| Common Stock Shares Authorized | 300,000,000 | 300,000,000 | 300,000,000 | 56,500,000 | -- | -- | -- |
| Common Stock Shares Outstanding | 58,533,226 | 58,533,226 | 57,864,186 | 7,020,487 | -- | -- | -- |
| Common Stock Value | $6,000.00 | $6,000.00 | $6,000.00 | $1,000.00 | -- | -- | -- |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | -- | -- | -- |
| Payments Of Dividends Common Stock | -- | -- | -- | -- | -- | -- | -- |
| Preferred Stock Shares Authorized | 10,000,000 | 10,000,000 | 10,000,000 | -- | -- | -- | -- |
| Preferred Stock Shares Outstanding | -- | -- | -- | -- | -- | -- | -- |
| Preferred Stock Value | -- | -- | -- | -- | -- | -- | -- |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | -- | -- | -- |
| Share Price | -- | -- | -- | -- | -- | -- | -- |